Key Opinion Leader in Head and Neck Cancer Introduces Investors to the Potential of Rakuten Medical’s Photoimmunotherapy-based Oncology Technology SAN DIEGO, March 1, 2023 /PRNewswire/ — Rakuten Medical, Inc., a global biotechnology company developing precision, cell-targeting therapies…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.